Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Wilfahrt

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature Immunology|January 18, 2024
Metabolic waypoints during T cell differentiationDrew Wilfahrt, Greg M Delgoffe
Elife|December 2, 2021
Histone deacetylase 3 represses cholesterol efflux during CD4<sup>+</sup> T-cell activationDrew Wilfahrt, Rachael L Philips, Jyoti Lama, et al.
The Journal of Experimental Medicine|August 8, 2023
An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironmentKristin DePeaux, Dayana B Rivadeneira, Konstantinos Lontos, et al.
Nature Cell Biology|April 21, 2025
Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell functionYupeng Wang, Drew Wilfahrt, Patrick Jonker, et al.
Cancer Immunology Research|August 19, 2025
Reprogramming CD8+ T-cell branched N-glycosylation limits exhaustion, enhancing cytotoxicity and tumor killingCatarina M Azevedo, Bingxian Xie, William G Gunn, et al.
Cell Metabolism|January 29, 2025
Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapyAndrew T Frisch, Yiyang Wang, Bingxian Xie, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature Immunology|January 18, 2024
Metabolic waypoints during T cell differentiationDrew Wilfahrt, Greg M Delgoffe
Elife|December 2, 2021
Histone deacetylase 3 represses cholesterol efflux during CD4<sup>+</sup> T-cell activationDrew Wilfahrt, Rachael L Philips, Jyoti Lama, et al.
The Journal of Experimental Medicine|August 8, 2023
An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironmentKristin DePeaux, Dayana B Rivadeneira, Konstantinos Lontos, et al.
Nature Cell Biology|April 21, 2025
Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell functionYupeng Wang, Drew Wilfahrt, Patrick Jonker, et al.
Cancer Immunology Research|August 19, 2025
Reprogramming CD8+ T-cell branched N-glycosylation limits exhaustion, enhancing cytotoxicity and tumor killingCatarina M Azevedo, Bingxian Xie, William G Gunn, et al.
Cell Metabolism|January 29, 2025
Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapyAndrew T Frisch, Yiyang Wang, Bingxian Xie, et al.
Pageof 1